mortality/aging
|
• irradiated mice survive longer than similarly treated wild-type mice
• irradiated mice do not die from glomerulonephritis
|
|
• mice exhibit premature death mostly due to glomerulonephritis and tumorigenesis
(J:70894)
• reduced viability is more pronounced in female mice compared to in wild-type mice
(J:70894)
• however, irradiated mice do not die from glomerulonephritis
(J:70894)
|
|
|
|
• female, but not male, mice exhibit age-dependent increase in premature death compared with wild-type mice
(J:60292)
|
reproductive system
|
|
• 1 Leydig cell adenoma and 1 malignant Leydig cell tumor with lung metastasis in 65 mice
|
immune system
| N |
• B cell proliferation is normal
|
|
• CD4+ T cell proliferation under conditions of sustained IL2 stimulation is increased compared with similarly treated wild-type cells
• CD4+CD44high T cells from male mice stimulated with IL2 exhibit increased proliferation compared with wild-type cells
• however, proliferation following initial activation and apoptosis levels are normal
|
|
• in 5 of 22 irradiated mice compared with 7 of 16 irradiated wild-type mice
|
|
• following irradiation, thymic lymphomas exhibit an increase in apoptosis compared to in wild-type mice
|
|
|
• in female, but not male, mice at 9 months
|
|
|
• in female, but not male, mice
|
|
|
• in female, but not male, mice
|
|
• at 9 months, mice exhibit an increase in the proportion of B cells in the lymph node compared to in wild-type mice
|
|
• at 4 and 9 months, mice exhibit an accumulation of memory/effector CD4+CD44high T cells in the spleen compared to in wild-type mice
• female mice exhibit a greater increase than male mice
|
|
• at 4 and 9 months, mice exhibit an accumulation of memory/effector CD4+CD44high T cells in the spleen compared to in wild-type mice
• female mice exhibit a greater increase than male mice
|
|
• at 9 to 12 months in male and female mice
|
|
• at 6 to 7 months, female mice exhibit a moderate increase in lymph node size compared with wild-type mice
• at 9 months, females and males exhibit dramatic and moderate, respectively, increases in lymph node size and weight compared to in wild-type mice
|
|
• cervical lymph node weight is increased in male and female mice compared to in wild-type mice
|
|
|
• female, but not male, mice exhibit a loss of tolerance towards nuclear antigens unlike in wild-type mice
|
|
• at 4 months in female, but not male, mice
• at 9 to 12 months in male and female mice
|
|
|
• older female, but not male, mice exhibit increased levels of IgG2a and IgG3 antibodies against dsDNA compared with wild-type mice
|
|
• at 9 to 12 months in male and female mice
|
|
• in 60% of female mice at an average age of 9.6 months
(J:70894)
• in 26% of male mice at an average age of 13.2 months
(J:70894)
|
|
|
|
• age-dependent and severe in female, but not male, mice
(J:60292)
|
respiratory system
|
• in 3 of 65 mice
|
neoplasm
|
• only one third of irradiated mice develop tumors (5 T cell lymphomas, 1 hemangiosarcoma, and 1 pituitary carcinoma in 22 mice) compared with 100% of similarly treated wild-type mice
|
|
• mice exhibit an increased incidence of tumor with an average lifespan of 16 months
|
|
• in 5 of 22 irradiated mice compared with 7 of 16 irradiated wild-type mice
|
|
• in 1 of 65 mice
|
|
|
• 1 Leydig cell adenoma and 1 malignant Leydig cell tumor with lung metastasis in 65 mice
|
|
• treatment with the chemical carcinogen, urethane, results in accelerated tumor onset and increased tumor multiplicity compared to controls; tumors are predominantly lung tumors
|
|
• in 2 of 65 mice (one keratoachantoma and one sebaceous gland adenoma)
|
|
• in 9 of 65 mice
|
|
• in 34 of 65 mice
|
|
• 1 in 22 irradiated mice develop pituitary carcinoma unlike irradiated wild-type mice
|
|
• in 3 of 65 mice
|
|
• in 14 of 65 mice
• in 1 of 22 irradiated mice compared with 3 of 16 irradiated wild-type mice
|
|
• 1 in 65 mice developed an urinary bladder tumor
|
renal/urinary system
|
|
• in female, but not male, mice
|
|
• in 60% of female mice at an average age of 9.6 months
(J:70894)
• in 26% of male mice at an average age of 13.2 months
(J:70894)
|
|
|
|
• age-dependent and severe in female, but not male, mice
(J:60292)
|
|
• 1 in 65 mice developed an urinary bladder tumor
|
|
• in 60% of female mice at an average age of 9.6 months
• in 26% of male mice at an average age of 13.2 months
|
homeostasis/metabolism
|
• following irradiation, thymic lymphomas exhibit an increase in apoptosis compared to in wild-type mice
|
|
|
• in female, but not male, mice
|
|
• irradiated mice survive longer than similarly treated wild-type mice
• irradiated mice do not die from glomerulonephritis
|
|
• only one third of irradiated mice develop tumors (5 T cell lymphomas, 1 hemangiosarcoma, and 1 pituitary carcinoma in 22 mice) compared with 100% of similarly treated wild-type mice
|
|
• treatment with the chemical carcinogen, urethane, results in accelerated tumor onset and increased tumor multiplicity compared to controls; tumors are predominantly lung tumors
|
hematopoietic system
|
• CD4+ T cell proliferation under conditions of sustained IL2 stimulation is increased compared with similarly treated wild-type cells
• CD4+CD44high T cells from male mice stimulated with IL2 exhibit increased proliferation compared with wild-type cells
• however, proliferation following initial activation and apoptosis levels are normal
|
|
• in 5 of 22 irradiated mice compared with 7 of 16 irradiated wild-type mice
|
|
• following irradiation, thymic lymphomas exhibit an increase in apoptosis compared to in wild-type mice
|
|
|
• in female, but not male, mice at 9 months
|
|
|
• in female, but not male, mice
|
|
|
• in female, but not male, mice
|
|
• at 9 months, mice exhibit an increase in the proportion of B cells in the lymph node compared to in wild-type mice
|
|
• at 4 and 9 months, mice exhibit an accumulation of memory/effector CD4+CD44high T cells in the spleen compared to in wild-type mice
• female mice exhibit a greater increase than male mice
|
|
• at 4 and 9 months, mice exhibit an accumulation of memory/effector CD4+CD44high T cells in the spleen compared to in wild-type mice
• female mice exhibit a greater increase than male mice
|
|
• at 9 to 12 months in male and female mice
|
cellular
|
• following irradiation, thymic lymphomas exhibit an increase in apoptosis compared to in wild-type mice
|
|
• CD4+ T cell proliferation under conditions of sustained IL2 stimulation is increased compared with similarly treated wild-type cells
• CD4+CD44high T cells from male mice stimulated with IL2 exhibit increased proliferation compared with wild-type cells
• however, proliferation following initial activation and apoptosis levels are normal
|
integument
|
• in 1 of 65 mice
|
|
• following ionizing radiation treatment, arrested cell growth in the epidermis is abrogated compared to in similarly treated wild-type mice
|
|
• in 2 of 65 mice (one keratoachantoma and one sebaceous gland adenoma)
|
endocrine/exocrine glands
|
• in 5 of 22 irradiated mice compared with 7 of 16 irradiated wild-type mice
|
|
• in 1 of 65 mice
|
|
|
• 1 Leydig cell adenoma and 1 malignant Leydig cell tumor with lung metastasis in 65 mice
|
|
• following irradiation, thymic lymphomas exhibit an increase in apoptosis compared to in wild-type mice
|
growth/size/body
|
|
• in female, but not male, mice at 9 months
|
|
|
• in female, but not male, mice
|
|
|
• in female, but not male, mice
|


Analysis Tools